360 ONE WAM Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 12, 2025, 10:37 pm

Competitors of 360 ONE WAM Ltd

All Competitor Stocks of 360 ONE WAM Ltd

Quarterly Result

Last Updated: August 1, 2025, 8:55 am

Below is a detailed analysis of the quarterly data for 360 ONE WAM Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 911.00 Cr.. The value appears strong and on an upward trend. It has increased from 821.00 Cr. (Mar 2025) to 911.00 Cr., marking an increase of 90.00 Cr..
• For Expenses, as of Jun 2025, the value is 346.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 360.00 Cr. (Mar 2025) to 346.00 Cr., marking a decrease of 14.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 566.00 Cr.. The value appears strong and on an upward trend. It has increased from 461.00 Cr. (Mar 2025) to 566.00 Cr., marking an increase of 105.00 Cr..
• For OPM %, as of Jun 2025, the value is 62.00%. The value appears strong and on an upward trend. It has increased from 56.00% (Mar 2025) to 62.00%, marking an increase of 6.00%.
• For Other Income, as of Jun 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 101.00 Cr. (Mar 2025) to 69.00 Cr., marking a decrease of 32.00 Cr..
• For Interest, as of Jun 2025, the value is 229.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 218.00 Cr. (Mar 2025) to 229.00 Cr., marking an increase of 11.00 Cr..
• For Depreciation, as of Jun 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 12.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 374.00 Cr.. The value appears strong and on an upward trend. It has increased from 324.00 Cr. (Mar 2025) to 374.00 Cr., marking an increase of 50.00 Cr..
• For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 24.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 285.00 Cr.. The value appears strong and on an upward trend. It has increased from 250.00 Cr. (Mar 2025) to 285.00 Cr., marking an increase of 35.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.04. The value appears strong and on an upward trend. It has increased from 6.35 (Mar 2025) to 7.04, marking an increase of 0.69.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:06 am

Growth

Last Updated: September 5, 2025, 1:56 pm

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for 360 ONE WAM Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 27.14. This value is within the healthy range. It has increased from 22.48 (Mar 24) to 27.14, marking an increase of 4.66.
• For Diluted EPS (Rs.), as of Mar 25, the value is 26.08. This value is within the healthy range. It has increased from 21.86 (Mar 24) to 26.08, marking an increase of 4.22.
• For Cash EPS (Rs.), as of Mar 25, the value is 27.62. This value is within the healthy range. It has increased from 23.99 (Mar 24) to 27.62, marking an increase of 3.63.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.73. It has increased from 96.12 (Mar 24) to 179.73, marking an increase of 83.61.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.73. It has increased from 96.12 (Mar 24) to 179.73, marking an increase of 83.61.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 83.82. It has increased from 69.85 (Mar 24) to 83.82, marking an increase of 13.97.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 60.85. This value is within the healthy range. It has increased from 47.61 (Mar 24) to 60.85, marking an increase of 13.24.
• For PBIT / Share (Rs.), as of Mar 25, the value is 59.06. This value is within the healthy range. It has increased from 46.03 (Mar 24) to 59.06, marking an increase of 13.03.
• For PBT / Share (Rs.), as of Mar 25, the value is 34.26. This value is within the healthy range. It has increased from 28.10 (Mar 24) to 34.26, marking an increase of 6.16.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 25.83. This value is within the healthy range. It has increased from 22.41 (Mar 24) to 25.83, marking an increase of 3.42.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 25.83. This value is within the healthy range. It has increased from 22.41 (Mar 24) to 25.83, marking an increase of 3.42.
• For PBDIT Margin (%), as of Mar 25, the value is 72.59. This value is within the healthy range. It has increased from 68.15 (Mar 24) to 72.59, marking an increase of 4.44.
• For PBIT Margin (%), as of Mar 25, the value is 70.45. This value exceeds the healthy maximum of 20. It has increased from 65.89 (Mar 24) to 70.45, marking an increase of 4.56.
• For PBT Margin (%), as of Mar 25, the value is 40.87. This value is within the healthy range. It has increased from 40.22 (Mar 24) to 40.87, marking an increase of 0.65.
• For Net Profit Margin (%), as of Mar 25, the value is 30.81. This value exceeds the healthy maximum of 10. It has decreased from 32.07 (Mar 24) to 30.81, marking a decrease of 1.26.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 30.81. This value exceeds the healthy maximum of 20. It has decreased from 32.07 (Mar 24) to 30.81, marking a decrease of 1.26.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.37. This value is below the healthy minimum of 15. It has decreased from 23.31 (Mar 24) to 14.37, marking a decrease of 8.94.
• For Return on Capital Employeed (%), as of Mar 25, the value is 31.74. This value is within the healthy range. It has increased from 15.63 (Mar 24) to 31.74, marking an increase of 16.11.
• For Return On Assets (%), as of Mar 25, the value is 5.13. This value is within the healthy range. It has decreased from 5.31 (Mar 24) to 5.13, marking a decrease of 0.18.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 2.02 (Mar 24) to 0.00, marking a decrease of 2.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.57. This value exceeds the healthy maximum of 1. It has decreased from 2.73 (Mar 24) to 1.57, marking a decrease of 1.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.18. It has decreased from 0.19 (Mar 24) to 0.18, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 1.5. It has decreased from 3.02 (Mar 24) to 1.44, marking a decrease of 1.58.
• For Quick Ratio (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has decreased from 3.02 (Mar 24) to 1.44, marking a decrease of 1.58.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 21.34. This value is within the healthy range. It has decreased from 73.36 (Mar 24) to 21.34, marking a decrease of 52.02.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.95. This value is below the healthy minimum of 20. It has decreased from 68.54 (Mar 24) to 19.95, marking a decrease of 48.59.
• For Earning Retention Ratio (%), as of Mar 25, the value is 78.66. This value exceeds the healthy maximum of 70. It has increased from 26.64 (Mar 24) to 78.66, marking an increase of 52.02.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.05. This value exceeds the healthy maximum of 70. It has increased from 31.46 (Mar 24) to 80.05, marking an increase of 48.59.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.70. This value is below the healthy minimum of 3. It has increased from 2.66 (Mar 24) to 2.70, marking an increase of 0.04.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.24. This value is below the healthy minimum of 3. It has decreased from 2.25 (Mar 24) to 2.24, marking a decrease of 0.01.
• For Enterprise Value (Cr.), as of Mar 25, the value is 47,066.59. It has increased from 32,996.85 (Mar 24) to 47,066.59, marking an increase of 14,069.74.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 14.28. This value exceeds the healthy maximum of 3. It has increased from 13.16 (Mar 24) to 14.28, marking an increase of 1.12.
• For EV / EBITDA (X), as of Mar 25, the value is 19.68. This value exceeds the healthy maximum of 15. It has increased from 19.31 (Mar 24) to 19.68, marking an increase of 0.37.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.25. This value exceeds the healthy maximum of 3. It has increased from 9.66 (Mar 24) to 11.25, marking an increase of 1.59.
• For Retention Ratios (%), as of Mar 25, the value is 78.65. This value exceeds the healthy maximum of 70. It has increased from 26.63 (Mar 24) to 78.65, marking an increase of 52.02.
• For Price / BV (X), as of Mar 25, the value is 5.25. This value exceeds the healthy maximum of 3. It has decreased from 7.02 (Mar 24) to 5.25, marking a decrease of 1.77.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.25. This value exceeds the healthy maximum of 3. It has increased from 9.66 (Mar 24) to 11.25, marking an increase of 1.59.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness